INTRODUCTION
A lymphocele is a lymphatic collection around the renal graft and urinary bladder. It can arise from either the lymph that drains through the lymphatic vessels in the sinus of the transplanted kidney or the lymphatic vessels surrounding the iliac vessels of the recipient. (1, 2) The reported incidence of lymphoceles ranges widely, from 1%-2% to as high as 20%. (1, 2) Factors associated with the aetiology of lymphoceles include acute rejection, length of surgery, extent of dissection and use of immunosuppressants. (1, 2) Small lymphoceles might be asymptomatic, but large ones can cause compression of the pelvicalyceal system, resulting in hydronephrosis and worsening renal function. Occurrence of a lymphocele following renal transplantation
The incidence of lymphoceles -lymphatic collections around a transplanted kidney -can be as high as 20%. We aimed to review the presentation, treatment and outcome of patients with lymphoceles.
METHODS
We reviewed a prospective database of 154 patients who underwent renal transplantation at our hospital from January 2005 to November 2008.
RESULTS
The mean age of the patients in our cohort was 46 (range 34-58) years. The incidence of lymphoceles in our series was 5.8% (n = 9). The median onset was 19 (range 6-28) days post-transplantation, while the median size of the lymphoceles was 5 (range 1.5-8) cm. Lymphoceles were most commonly found at the lower pole of the transplanted kidney. Eight patients with lymphoceles had received cadaveric transplants. While a majority of these patients did not have hydronephrosis on presentation, four had markedly elevated creatinine. Of the nine patients with lymphoceles, six were on macrolides (tacrolimus, sirolimus or everolimus), two were successfully managed conservatively, three were managed percutaneously and four required surgical drainage via either laparoscopic marsupialisation (n = 1) or open drainage (n = 3). There was no graft loss.
CONCLUSION It remains unknown whether the choice of immunosuppressants increases the risk of lymphocele
formation. Intervention is necessary in the case of impaired drainage of the pelvicalyceal system in these patients. Minimally invasive intervention, while effective in treating lymphoceles, does not provide definitive treatment. Surgical intervention should be considered early for the treatment of post-transplantation patients with lymphoceles, so as to shorten hospital stay and prevent further complications. (44.4%) had clinically elevated creatinine levels (Table I) , and 6 (66.7%) were on macrolides such as tacrolimus, sirolimus and everolimus. Although there were no delayed graft functions, there was one case of acute graft rejection.
Of the nine patients with lymphoceles, five were initially treated conservatively (Fig. 1) . Among these five patients, three required subsequent intervention in the form of either percutaneous drainage or surgical intervention -two were managed successfully using percutaneous drainage, and one 
DISCUSSION
The reported incidence of symptomatic lymphoceles in the literature is 0.6%-18.0%. (1) The incidence of lymphoceles in our study was 5.8% (n = 9), which is comparable to that reported in the literature. Although lymphoceles can be harmless and asymptomatic in many patients, they can also seriously affect renal function and may necessitate surgical intervention.
Although asymptomatic lymphoceles do not require therapy, it is important that regular ultrasonographic monitoring continues until the collection is resolved. In the case of a large or symptomatic collection, therapy aims to efficiently and completely remove the collection. However, there is no gold standard of treatment for lymphoceles.
Percutaneous aspiration of the collection is associated with a high incidence (50%-100%) of recurrence. to reduce the risk of recurrence (range 13%-33%), (7) (8) (9) as has additional sclerotherapy (range 6%-25%). (2, 4, 7) Common sclerosing agents used in sclerotherapy are doxycycline and ethanol.
Other sclerosing agents include povidone-iodine, talc and bleomycin. The use of sclerosing agents is generally considered safe and highly successful, although some reports have suggested that they have toxic effects on graft functions and may even cause graft loss. (10, 11) Surgical interventions for lymphoceles include marsupialisation, or external drainage via open or laparoscopic technique. The recurrence rates of lymphoceles following laparoscopic marsupialisation (range 6%-12%) (2, 7) and open drainage (range 6.7%-13%) (3, 7) are comparable. Laparoscopic marsupialisation is the recommended surgical intervention for lymphoceles, as it is less invasive, and has shorter operative time and hospital stay, as well as better cosmesis. In our study, conservative and less invasive treatment, such as percutaneous drainage, was successful in 55.5% of patients.
Among the four patients who had surgical intervention, one underwent laparoscopic marsupialisation and three underwent open drainage. Consistent with the results from other centres, (12) three of these patients had larger sized lymphoceles (> 6 cm in diameter). We opted to perform open drainage in three patients under surgical intervention, as two of them had a history of previous abdominal surgery and one patient's collection was close to the hilum. There was no recurrence of lymphocele in any of our patients, regardless of the kind of treatment (percutaneous or surgical) used.
Although the surgical management of lymphoceles has remained largely unchanged, it remains unclear whether the introduction of newer immunosuppressants, such as tacrolimus, sirolimus and everolimus, has contributed to the increasing numbers of patients developing lymphoceles after renal transplantation. While studies have shown that sirolimus is a powerful immunosuppressant for renal transplant recipients, (13, 14) its use has been associated with a higher frequency of lymphocele formation. (13) According to Srivastava et al, the incidence of lymphocele in patients treated with sirolimus is slightly higher than in those receiving mycophenolate mofetil. (15) Even though the exact reasons for the development of lymphocele are still uncertain, avoiding the use of sirolimus in renal transplant recipients at the early postoperative period may help to reduce the incidence of lymphocele in these patients. Based on the results obtained from our local setting, we have developed an algorithm for the management of post-transplantation lymphoceles (Fig. 2) .
The initial decision on whether a post-transplantation patient with lymphocele should be treated conservatively would depend on factors such as the size of the lymphocele, the symptoms observed, as well as the presence of hydronephrosis, impaired renal function or concomitant infection. If treatment is warranted, percutaneous drainage should be offered to patients.
However, for patients with a collection > 6 cm in diameter, surgical options should be considered. In the event of a failed percutaneous intervention, surgical drainage should be offered to the patient. Laparoscopic drainage may also be offered, unless contraindicated due to small volume (< 100 mL) of fluid, previous abdominal surgery, suspicion of infection, as well as location of lymphocele near the bladder, ureter or renal hilum.
In summary, the incidence of lymphocele was 5.8% in our series. Even though surgical techniques have remained unchanged for the most part, it is still unclear whether the introduction of newer immunosuppressants has contributed to the higher incidence of lymphoceles in post-renal transplantation patients. Intervention is required if the lymphocele causes an impairment in the drainage of the pelvicalyceal system. We found that although minimally invasive intervention was effective in treating lymphoceles, it did not provide a definitive treatment.
Percutaneous drainage was found to be consistently associated with a higher recurrence rate, prolonged hospital stay, higher costs and more complications. Surgical intervention should be considered earlier in the treatment of patients with posttransplantation lymphoceles so as to shorten hospital stay and prevent further complications. 
